Abstract:RNA interference (RNAi) inhibits gene expression by specifically degrading target mRNAs. Since the discovery of double-stranded small interference RNA (siRNA) in gene silencing(1), RNAi has become a powerful research tool in gene function studies. Compared to genetic deletion, RNAi-mediated gene silencing possesses many advantages, such as the ease with which it is carried out and its suitability to most cell lines. Multiple studies have demonstrated the applications of RNAi technology in cancer research. In particular, the development of the DNA vectorbased technology to produce small hairpin RNA (shRNA) driven by the U6 or H1 promoter has made long term and inducible gene silencing possible(2,3). Its use in combination with genetically engineered viral vectors, such as lentivirus, facilitates high efficiencies of shRNA delivery and/or integration into genomic DNA for stable shRNA expression.We describe a detailed procedure using the DNA vector-based RNAi technology to determine gene function, including construction of lentiviral vectors expressing shRNA, lentivirus production and cell infection, and functional studies using a mouse xenograft model.Various strategies have been reported in generating shRNA constructs. The protocol described here employing PCR amplification and a 3-fragment ligation can be used to directly and efficiently generate shRNA-containing lentiviral constructs without leaving any extra nucleotide adjacent to a shRNA coding sequence. Since the shRNA-expression cassettes created by this strategy can be cut out by restriction enzymes, they can be easily moved to other vectors with different fluorescent or antibiotic markers. Most commercial transfection reagents can be used in lentivirus production. However, in this report, we provide an economic method using calcium phosphate precipitation that can achieve over 90% transfection efficiency in 293T cells. Compared to constitutive shRNA expression vectors, an inducible shRNA system is particularly suitable to knocking down a gene essential to cell proliferation. We demonstrate the gene silencing of Yin Yang 1 (YY1), a potential oncogene in breast cancer(4,5), by a Tet-On inducible shRNA system and its effects on tumor formation. Research using lentivirus requires review and approval of a biosafety protocol by the Biosafety Committee of a researcher's institution. Research using animal models requires review and approval of an animal protocol by the Animal Care and Use Committee (ACUC) of a researcher's institution.

Tissue-Specific RNAi Expression in Transgenic Mice

Application of short hairpin RNAs (shRNAs) to study gene function in mammalian systems

shRNA Transcribed by RNA Pol II Promoter Induce RNA Interference in Mammalian Cell

[Shrnas Driven by K14 Promoter Induce Tissue-Specific RNA Interference].

Transgenic RNA interference in mice.

A More Efficient RNAi Inducible System for Tight Regulation of Gene Expression in Mammalian Cells and Xenograft Animals.

Development of a species-specific RNA polymerase I-based shRNA expression vector

A pipeline for the generation of shRNA transgenic mice

Adapted Resistance To The Knockdown Effect Of Shrna-Derived Srsf3 Sirnas In Mouse Littermates

Tissue-specific RNA interference in postimplantation mouse embryos with endoribonuclease-prepared short interfering RNA

RNAi-based Conditional Gene Knockdown in Mice Using a U6 Promoter Driven Vector

A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference

Application of RNA Interference in Mammalian Cells

The Application of RNAi Technology in Transgenic Mice

RNA interference with small hairpin RNAs transcribed from a human U6 promoter-driven DNA vector.

Gene silencing in mammalian cells by PCR-based short hairpin RNA.

RNAi in mice: a promising approach to decipher gene functions in vivo

20 RNA Interference in Mouse Models

Tissue-Targeting of RNA Interference

DNA Vector-Based RNA Interference to Study Gene Function in Cancer.